2005 Doctors Healthcare Specialization 
PM360
AUGUST 9, 2022
According to a 2021 study by Statista, 40% of prescriptions written in 2005 were for brand-name medications. Pharma companies have shifted their focus to specialized conditions such as multiple sclerosis and ulcerative colitis. By 2020, that percentage plummeted to just 8%. References: 1.
Pharmaceutical Technology
OCTOBER 5, 2022
In 2009, former Biogen employee Michael Bawduniak filed a lawsuit claiming that Biogen had violated the False Claims Act and the Anti-Kickback Statute by providing millions of dollars to healthcare providers (HCPs) as an incentive to prescribe three of its multiple sclerosis (MS) drugs. Biogen’s activity in multiple sclerosis.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
NOVEMBER 24, 2022
Tackling pharmaceutical counterfeiting continues, therefore, to be a clear and present priority for manufacturers, healthcare authorities and law enforcement. The subsequent high percentage of fakes led to doctors losing confidence in the brands and no longer prescribing them. Quality assurances through the use of holograms.
Evolve Your Success
FEBRUARY 6, 2024
. — Watch the episode here Listen to the podcast here Medical Sales In Sterile Processing And Infection Prevention With Mark Copeland We have with us another special guest and he goes by the name of Mark Copeland. Mark Copeland has an experience in medical device sales with 18 years in the game and 27 in healthcare. They got big.
Cadensee
JULY 26, 2021
Liron Fendell is the CEO of Nutritional Growth Solutions, or NGS, that specializes in scientific supplement formulas for children of a small stature. And I was lucky enough the team at Schneider's and Clalit Healthcare , who is the owner of Schneider Hospital. They want it to be backed by doctors. Liron Fendell. Show Notes.
Expert insights. Personalized for you.
52 
Let's personalize your content